早间新闻

瑞讯分析师提供的市场策略

Akzo Nobel to Sell Southeast Asia Decorative Paints Business

作者:Igor JOVICIC
Oct 5, 2026
Akzo Nobel AKZA has agreed to sell its decorative paints business in Southeast Asia to Nippon Paint 4612 at an enterprise value of $1.35 billion. The Dutch paint company said Monday that net cash proceeds after taxes and minority partners are expected to be about $1 billion.

Nike Plans a Smaller Company as Sales Slide Deepens

作者:Igor JOVICIC
Oct 2, 2026
Nike NKE is planning to be a smaller company. After two straight quarters of falling revenue, Nike said it expects sales to keep declining this fiscal year and it will shrink its operations, cut jobs and merge regional businesses to adjust. “This work will result in fewer roles across Nike,” Chief Executive Elliott Hill wrote in a memo to employees.

Micron Profit, Revenue Surge as Memory Crunch Looks to Last Through 2028

作者:Stefano GIANTI
Oct 1, 2026
Micron MU Technology profit and revenue surged in the fiscal fourth quarter, as the company said the shortage of memory chips that has propelled its explosive growth in the past year shows no signs of slowing down. “Industry demand has strengthened since our last earnings call, and we expect memory and storage supply demand conditions to be much tighter in fiscal 2027 and 2028 than they were in 2026,” Chief Executive Sanjay Mehrotra said on a Wednesday call with analysts. Mehrotra’s comments come as investors have debated the durability of the memory shortage that has fueled Micron’s blowout earnings.

Oura Postpones IPO Over Market Uncertainty

作者:Igor JOVICIC
Sep 30, 2026
Smart-ring maker Oura said it was delaying its previously announced initial public offering due to market uncertainty. The San Francisco-based company, which was expected to fetch a valuation well above the $11 billion achieved in a funding round last year, said Tuesday it was postponing its listing “despite strong demand, due to uncertainty in the IPO market.” Oura made its IPO paperwork public earlier this month. It said the issue had attracted strong investor demand, but that the timing wasn’t right. The company was aiming to list on the Nasdaq as soon as this month.

AMD to Acquire World Labs for $8.2 Billion

作者:Igor JOVICIC
Sep 29, 2026
Advanced Micro Devices AMD agreed to acquire artificial-intelligence research firm World Labs in an all-stock deal valued at about $8.2 billion, an acquisition that reflects chip makers’ ambitions to control more of the AI stack. AMD, a semiconductor company that recently touched a $1 trillion valuation, said the deal would bring leading AI research and development talent and help the company develop better AI hardware, software and systems, especially in the growing field of physical AI and robotics. World Labs focuses on spatially intelligent AI models that can generate and simulate interactive 3-D environments.

Chemicals Giant BASF Moves for German Rival Evonik

作者:Stefano GIANTI
Sep 28, 2026
German chemicals producer BASF BAS said it entered initial talks over a takeover of smaller peer Evonik, a tie-up that would bolster BASF’s dominant position in Europe’s chemicals industry.

Anthropic to Pay Akamai Technologies $11.6 Billion for Cloud Services

作者:Stefano GIANTI
Sep 25, 2026
Anthropic will pay Akamai Technologies AKAM at least $11.6 billion to use its cloud infrastructure and software for over seven years in an expansion of the partnership between the two companies.

OpenAI Agent Hacked Australian Government Website

作者:Stefano GIANTI
Sep 24, 2026
An OpenAI agent infiltrated a government-services website in Australia this summer, Prime Minister Anthony Albanese said Wednesday at the United Nations meeting in New York.

Meta’s New AI Agent Is an Instant Hit—and the Backlash Has Already Begun

作者:Stefano GIANTI
Sep 23, 2026
Meta Platforms (-0.6%) appears to have a hit AI product on its hands, but the company’s path to ultimate domination in this next chapter of consumer AI use is anything but assured. Two weeks ago, Meta launched a new, easy-to-use personal AI agent called Muse. The app, which is how users access the agent, has been sitting at No. 1 on Apple’s U.S.

Roche's Eye Drug Susvimo Obtains EU Approval

作者:Igor JOVICIC
Sep 22, 2026
Roche will be able to market its eye medication Susvimo in the European Union. As the Swiss pharmaceutical company announced, the European Commission has granted approval. Susvimo is a treatment for neovascular age-related macular degeneration.
Switzerland

源自瑞士匠心设计

了解风险

在外汇交易平台上交易杠杆产品,例如外汇,现货金属和差价合约,都会因杠杆效应而面临重大的亏损风险,因而并不适合所有投资者。在开立瑞讯之交易帐户前,请考虑个人经验水平、投资目标、资产、收入和可承担之风险水平。理论上,亏损是可以无上限,如果帐户余额低于所需保证金水平,您有可能被追加资金,因此您不应该以自己无法承受亏损的资金进行交易,即您不应借入资金或以个人或家庭生活所急需或必要的资金进行投机、投资或对冲。过去 12 个月,68.22%的零售投资者在交易差价合约时出现亏损、在平仓时损失全部保证金或平仓后帐户出现负值。您必须清楚了解外汇交易中所有相关风险,如果有任何疑问时,应及时向独立财务顾问寻求建议。如需更多资料,包括杠杆的影响、保证金交易的操作以及交易对手和市场风险,请参阅我们的外汇和差价合约风险披揭露。本网页之内容包含市场推广讯息,内容并没有提交亦没有得到相关监管机构之批核。

AI 生成内容

本网站部分可视化内容由人工智能 (AI) 应用程序生成和/或优化,但所有内容均经过严格的人工审批流程,以确保其准确性、相关性并符合用户与客户的需求。